Skip to main content

Day: January 26, 2021

VoIP-Pal Provides a Status Update on the Petition for a Writ of Mandamus with the U.S. Court of Appeals for the Federal Circuit

The Company seeks to overturn the Northern District of California District Court’s order in its cases vs. Apple, Verizon, and AT&TBELLEVUE, Wash., Jan. 26, 2021 (GLOBE NEWSWIRE) — VoIP-Pal.com Inc. (“VoIP-Pal”, “Company”) (OTCQB: VPLM) announces that on January 14, 2021, the Court of Appeals for the Federal Circuit (CAFC) ordered additional and expedited briefings on the mandamus petition filed by VoIP-Pal on January 12, 2021. The responsive brief by the respondents, Apple, Verizon, and AT&T was filed on January 21, 2021, as ordered by the Court and the reply by VoIP-Pal was filed on January 25, 2021.Additionally, on January 14, 2021, the District Court for the Northern District of California ordered a stay on all of VoIP-Pal’s cases currently before that Court pending the outcome of the petition for mandamus. As was previously...

Continue reading

Active Biotech’s rights issue heavily oversubscribed

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN OR CANADA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES BEYOND WHAT IS REQUIRED UNDER SWEDISH LAW  Active Biotech AB’s (publ) (”Active Biotech”) rights issue with pre-emptive rights for Active Biotech’s shareholders has been heavily oversubscribed. Active Biotech will thereby raise approximately SEK 76.2 million before deduction of issue expenses.Following the end of the subscription period, the results of Active Biotech’s rights issue show that 69,393,895 shares, corresponding to approximately 96 percent of the shares offered, were subscribed for with subscription rights. In addition, applications to subscribe for 127,429,659...

Continue reading

Active Biotechs företrädesemission kraftigt övertecknad

EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, JAPAN ELLER KANADA ELLER I NÅGON ANNAN JURISDIKTION DÄR DISTRIBUTION AV DETTA PRESSMEDDELANDE SKULLE VARA OLAGLIG ELLER KRÄVA REGISTRERING ELLER ANDRA ÅTGÄRDER UTÖVER VAD SOM FÖLJER AV SVENSK RÄTT. Active Biotech AB:s (publ) (”Active Biotech”) nyemission med företrädesrätt för Active Biotechs aktieägare har kraftigt övertecknats. Active Biotech tillförs därigenom en emissionslikvid om cirka 76,2 miljoner kronor, före emissionskostnader.Efter avslutad teckningsperiod visar sammanräkningen i Active Biotechs företrädesemission att 69 393 895 aktier, motsvarande cirka 96 procent av de erbjudna aktierna, tecknades med stöd av teckningsrätter. Därtill har anmälningar för teckning utan stöd av teckningsrätter motsvarande 127 429 659...

Continue reading

MEDESIS PHARMA LANCE SON INTRODUCTION EN BOURSE SUR EURONEXT GROWTH PARIS®

MEDESIS PHARMA LANCE SON INTRODUCTIONEN BOURSE SUR EURONEXT GROWTH PARIS®Lancement de 3 études de Phase II dès 2021Offre globale de 5,6 M€1 pouvant être portée à 7,4 M€Offre couverte à 95,7% par des engagements de souscription de 5,3 M€(dont 1,4 M€ par les actionnaires historiques)Placement global et Offre à Prix Ouvert du 26 janvier au 8 février 2021Fourchette de prix : 5,00 à 6,76 euros par actionMontpellier, le 26 janvier 2021 – MEDESIS PHARMA, société de biotechnologie pharmaceutique, annonce le lancement de son introduction en Bourse en vue de l’admission aux négociations de ses actions sur Euronext Growth Paris® (ISIN : FR0010844464, MNEMO : ALMDP).Une technologie d’administration des principes actifs pour une efficacité accrue et une toxicité réduitePour avancer dans le traitement des maladies graves dépourvues de traitement...

Continue reading

Bombardier launches major investment plan to modernize and increase production capacity of its factory in Bruges

The increase in production capacity as well as the modernization of the Bombardier site in Bruges, will be funded by an investment of more than six million euroThis investment plan supports the hiring of at least 180 additional employeesDirect investments in our suppliers, to support the production increase, are also part of the fundingBERLIN, Jan. 26, 2021 (GLOBE NEWSWIRE) —Note to editors: To view the photos associated with this press release, please visit the following links:https://www.globenewswire.com/NewsRoom/AttachmentNg/13188f50-db91-4fe6-9a40-b4df727e63dehttps://www.globenewswire.com/NewsRoom/AttachmentNg/9721e170-5444-42ab-a063-289506dbf207Global mobility leader Bombardier Transportation has announced today the launch of a major investment and hiring plan aimed at increasing the production capacity of its factory in Bruges,...

Continue reading

Bombardier lance un plan d’investissement majeur visant à moderniser et à augmenter la capacité de production de son usine de Bruges

L’augmentation de la capacité de production et la modernisation de l’usine Bombardier de Bruges seront financées par un investissement de plus de 6 millions d’euros.Ce plan d’investissement s’accompagne de l’embauche d’au moins 180 salariés supplémentaires.Des investissements directs chez les fournisseurs de Bombardier leur permettront d’accompagner l’augmentation de la production.BERLIN, 26 janv. 2021 (GLOBE NEWSWIRE) —Note aux rédacteurs : Pour voir les photos associées à ce communiqué, veuillez visiter les liens suivants :https://www.globenewswire.com/NewsRoom/AttachmentNg/13188f50-db91-4fe6-9a40-b4df727e63dehttps://www.globenewswire.com/NewsRoom/AttachmentNg/9721e170-5444-42ab-a063-289506dbf207Bombardier Transport, un chef de file mondial du secteur des technologies ferroviaires, a annoncé le lancement d’un plan d’investissement...

Continue reading

Bombardier lanceert een belangrijk investeringsplan om de productiecapaciteit van zijn fabriek in Brugge te moderniseren en te verhogen

De verhoging van de productiecapaciteit en de modernisering van de Bombardier-site in Brugge worden gefinancierd door een investering van meer dan zes miljoen euroDit investeringsplan ondersteunt de aanwerving van (ten minste) 180 extra medewerkersDirecte investeringen in onze leveranciers, om de productieverhoging te ondersteunen, maken ook deel uit van het investeringsplanBERLIJN, Jan. 26, 2021 (GLOBE NEWSWIRE) —Noot voor de redactie: Om de foto’s te zien die bij dit persbericht horen, gaat u naar de volgende links:https://www.globenewswire.com/NewsRoom/AttachmentNg/13188f50-db91-4fe6-9a40-b4df727e63dehttps://www.globenewswire.com/NewsRoom/AttachmentNg/9721e170-5444-42ab-a063-289506dbf207Bombardier Transportation, wereldleider op het gebied van mobiliteit, heeft vandaag de lancering aangekondigd van een belangrijk investerings-...

Continue reading

Huize Preannounces Preliminary Estimated Unaudited Operating Revenue for Fourth Quarter 2020

SHENZHEN, China, Jan. 26, 2021 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading independent online long-term life and health insurance product and service platform in China, today announced its preliminary estimated unaudited total operating revenue and selected operating data for the fourth quarter of 2020.Total operating revenue for the fourth quarter of 2020 is expected to be at least RMB380 million, representing a record quarterly high and a year-over-year growth of 47.1%, exceeding the Company’s previous guidance of RMB330 million to RMB350 million.Total Gross Written Premiums (“GWP”) facilitated on the Company’s platform are expected to be approximately RMB1,000 million in the fourth quarter of 2020, representing a record quarterly high and an increase of 55.7% compared...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.